OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
Patrizia LoPresti
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1077-1077
Open Access | Times Cited: 11

Showing 11 citing articles:

Neurological complications caused by SARS-CoV-2
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 8

The Genomic Intersection of Oligodendrocyte Dynamics in Schizophrenia and Aging Unravels Novel Pathological Mechanisms and Therapeutic Potentials
Andrea Rivera, John R. Normanton, Arthur M. Butt, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4452-4452
Open Access | Times Cited: 5

The Blood Concentration of Metallic Nanoparticles Is Related to Cognitive Performance in People with Multiple Sclerosis: An Exploratory Analysis
Marcela de Oliveira, Felipe Balistieri Santinelli, Paulo Noronha Lisboa‐Filho, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1819-1819
Open Access | Times Cited: 11

Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis
Smaranda Maier, Laura Bărcuțean, Sebastian Andone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4375-4375
Open Access | Times Cited: 10

Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice
Alin Ciubotaru, Mădălina Irina Smihor, Cristina Grosu, et al.
Diagnostics (2025) Vol. 15, Iss. 9, pp. 1178-1178
Open Access

From progression to progress: The future of multiple sclerosis
Jiwon Oh, Paul S. Giacomini, V. Wee Yong, et al.
Journal of Central Nervous System Disease (2024) Vol. 16
Open Access | Times Cited: 3

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
Anna Pafiti, George Krashias, John S. Tzartos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10787-10787
Open Access | Times Cited: 7

Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo 1H-MRS studies
Yinghua Jing, Imis Dogan, Kathrin Reetz, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106574-106574
Open Access | Times Cited: 1

Molecular biomarkers and cognitive impairment in multiple sclerosis: A review
Sara Esmaeili, Ahmed Z. Obeidat, Aram Zabeti
Biomarkers in Neuropsychiatry (2023) Vol. 9, pp. 100077-100077
Open Access | Times Cited: 3

Biomarkers in Multiple Sclerosis: Analysis of the Present Advantages and Look to the Future
Valentina Ignatova
Journal of Psychology and Neuroscience (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top